To ensure that patient access to pain medications is not impeded by enforcement activity, the Drug Enforcement Administration should provide better guidance to distributors of controlled substances concerning their role in monitoring and reporting suspicious drug orders, the Government Accountability Office said in a June report to members of Congress. The report, Prescription Dru... Read More